Fig. 1From: Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trialLongitudinal EQ-5D index. *Footnote of Fig. 1: This figure shows estimates of the least-square means for EQ-5D value and 95% confidence intervals. Black circle indicates values of S-1 group, and white square does those of taxane groupBack to article page